March 9, 2026
TOPLINE: High-intensity circuit training (HICT) combined with a sleep health (SH) intervention was linked to greater improvements in sleep outcomes and cardiometabolic health compared with either […]
March 6, 2026
A novel first-in-class gene-regulation therapy for Dravet syndrome was associated with large reductions in seizures and improved functional outcomes in children with Dravet syndrome. Results from […]
March 6, 2026
TOPLINE: Traumatic brain injury (TBI) was associated with a persistently increased risk for work disability across all severity groups, and this risk was influenced by sociodemographic […]
March 6, 2026
The brains of superagers — octogenarians with a memory capacity that rivals that of younger adults — generate more than twice as many new neurons as […]
March 6, 2026
TOPLINE: Life expectancy varied greatly on the basis of impairments in motor function, feeding ability, and continence in patients with open spina bifida, with fewer years […]
March 5, 2026
GLP-1s have been a breakthrough for obesity and diabetes. A 2022 study examined data from trials of GLP-1s in nearly 16,000 patients with diabetes, and showed […]
March 4, 2026
TOPLINE: Patients with migraine had a higher risk of developing depression or anxiety than individuals without migraine, and this elevated risk persisted after accounting for shared […]
March 2, 2026
Healthy eating in midlife was associated with better cognitive performance and lower risk of subjective cognitive decline (SCD) in three large prospective studies of US health […]
March 2, 2026
Efgartigimod (Vyvgart, argenx) led to statistically significant improvements in symptoms of ocular myasthenia gravis (MG) in the phase 3 ADAPT OCULUS trial, according to topline results […]